How to use the speech recognition tool?
A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176.
Status of the trial: Completed
Orphan Drug Recognition: NA
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators